Medicure Inc. (OTCMKTS:MCUJF – Get Free Report) shares crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.71 and traded as low as $0.53. Medicure shares last traded at $0.53, with a volume of 420 shares.
Medicure Stock Down 10.8 %
The company has a quick ratio of 1.64, a current ratio of 2.03 and a debt-to-equity ratio of 0.03. The company’s fifty day simple moving average is $0.64 and its 200 day simple moving average is $0.71. The firm has a market capitalization of $5.55 million, a PE ratio of -3.80 and a beta of 1.00.
Medicure Company Profile
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Read More
- Five stocks we like better than Medicure
- The 3 Best Blue-Chip Stocks to Buy Now
- 4 Social Media Stocks Set to Gain as TikTok Ban Looms
- What Does a Stock Split Mean?
- How Do Stock Buybacks Affect Shareholders?
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- JPMorgan Chase & Co. Stock Can Hit $300 This Year
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
